Literature DB >> 33917629

Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation.

Virgil Schijns1,2, Dragomira Majhen3, Peter van der Ley1, Aneesh Thakur4, Artur Summerfield5,6, Rita Berisio7, Cristina Nativi8, Alberto Fernández-Tejada9,10, Carmen Alvarez-Dominguez11, Sveinbjörn Gizurarson12,13, Alla Zamyatina14, Antonio Molinaro15,16, Camillo Rosano17, Žiga Jakopin18, Ihsan Gursel19, Siobhán McClean20.   

Abstract

Vaccines are the most effective medical intervention due to their continual success in preventing infections and improving mortality worldwide. Early vaccines were developed empirically however, rational design of vaccines can allow us to optimise their efficacy, by tailoring the immune response. Establishing the immune correlates of protection greatly informs the rational design of vaccines. This facilitates the selection of the best vaccine antigens and the most appropriate vaccine adjuvant to generate optimal memory immune T cell and B cell responses. This review outlines the range of vaccine types that are currently authorised and those under development. We outline the optimal immunological correlates of protection that can be targeted. Finally we review approaches to rational antigen selection and rational vaccine adjuvant design. Harnessing current knowledge on protective immune responses in combination with critical vaccine components is imperative to the prevention of future life-threatening diseases.

Entities:  

Keywords:  adjuvant; antigen; delivery system; design; immunization; rational; route; vaccine

Year:  2021        PMID: 33917629     DOI: 10.3390/pharmaceutics13040501

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  3 in total

1.  Systems Immunology Analyses Following Porcine Respiratory and Reproductive Syndrome Virus Infection and Vaccination.

Authors:  Loïc Vivien Bocard; Andrew Robert Kick; Corinne Hug; Heidi Erika Lisa Lischer; Tobias Käser; Artur Summerfield
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

2.  Structure based design of effective HtpG-derived vaccine antigens against M. tuberculosis.

Authors:  Alessia Ruggiero; Han-Gyu Choi; Giovanni Barra; Flavia Squeglia; Young Woo Back; Hwa-Jung Kim; Rita Berisio
Journal:  Front Mol Biosci       Date:  2022-08-11

Review 3.  Immunostimulant plant proteins: Potential candidates as vaccine adjuvants.

Authors:  Jilan A Nazeam; Abdel Nasser B Singab
Journal:  Phytother Res       Date:  2022-09-20       Impact factor: 6.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.